Clinical Studies - Biopharmaceutical Regulatory Affairs Market Statistics
The global clinical studies biopharmaceutical regulatory affairs market size was valued at US$ 1,767.4 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030.
Related Statistics
Clinical studies - Biopharmaceutical regulatory affairs market highlights
- The global clinical studies segment generated a revenue of USD 1,767.4 million in 2023 and is expected to reach USD 3,085.3 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.3% by 2030.
- In terms of region, Asia Pacific was the largest revenue generating market in 2023.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Market summary
| Market revenue in 2023 | USD 1,767.4 million |
| Market revenue in 2030 | USD 3,085.3 million |
| Growth rate | 8.3% (CAGR from 2024 to 2030) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Regulatory Affairs Market Scope
Biopharmaceutical regulatory affairs market segmentation & scope
Biopharmaceutical Regulatory Affairs Market Outlook
- HTML
- PPT
- -
Everything on Biopharmaceutical Regulatory Affairs Market in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
